The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Six-Minute-Walk Test in Idiopathic Pulmonary Fibrosis: Test Validation and Minimal Clinically Important Difference
Open accessAbstract
RATIONALE: The 6-minute-walk test (6MWT) is a practical and clinically meaningful measure of exercise tolerance with favorable performance characteristics in various cardiac and pulmonary diseases. Performance characteristics in patients with idiopathic pulmonary fibrosis (IPF) have not been systematically evaluated. OBJECTIVES: To assess the reliability, validity, and responsiveness of the 6MWT and estimate the minimal clinically important difference (MCID) in patients with IPF. METHODS: The study population included all subjects completing a 6MWT in a clinical trial evaluating interferon gamma-1b (n = 822). Six-minute walk distance (6MWD) and other parameters were measured at baseline and at 24-week intervals using a standardized protocol. Parametric and distribution-independent correlation coefficients were used to assess the strength of the relationships between 6MWD and measures of pulmonary function, dyspnea, and health-related quality of life. Both distribution-based and anchor-based methods were used to estimate the MCID. MEASUREMENTS AND MAIN RESULTS: Comparison of two proximal measures of 6MWD (mean interval, 24 d) demonstrated good reliability (coefficient = 0.83; P < 0.001). 6MWD was weakly correlated with measures of physiologic function and health-related quality of life; however, values were consistently and significantly lower for patients with the poorest functional status, suggesting good construct validity. Importantly, change in 6MWD was highly predictive of mortality; a 24-week decline of greater than 50 m was associated with a fourfold increase in risk of death at 1 year (hazard ratio, 4.27; 95% confidence interval, 2.57- 7.10; P < 0.001). The estimated MCID was 24-45 m. CONCLUSIONS: The 6MWT is a reliable, valid, and responsive measure of disease status and a valid endpoint for clinical trials in IPF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Clinical Practice Guideline: Otitis Media with Effusion (Update)
Rosenfeld, R. M., Shin, J. J., Schwartz, S. R., Coggins, R., Gagnon, L., Hackell, J. M., Hoelting, D., Hunter, L. L., Kummer, A. W., Payne, S. C., et al. (2016) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599815623467 · Cited by 2,006
Methods to Explain the Clinical Significance of Health Status Measures
Guyatt, G. H., Osoba, D., Wu, A. W., Wyrwich, K. W., & Norman, G. R. (2002) · Mayo Clinic Proceedings · doi:10.4065/77.4.371 · Cited by 1,500
Solway, S., Brooks, D., Lacasse, Y., & Thomas, S. (2001) · Chest · doi:10.1378/chest.119.1.256 · Cited by 1,063
Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis
BJORAKER, J. A., RYU, J. H., EDWIN, M. K., MYERS, J. L., TAZELAAR, H. D., SCHROEDER, D. R., & OFFORD, K. P. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.1.9704130 · Cited by 1,039
Redelmeier, D. A., Bayoumi, A. M., Goldstein, R. S., & Guyatt, G. H. (1997) · American journal of respiratory and critical care medicine · doi:10.1164/ajrccm.155.4.9105067 · Cited by 1,029
Wyrwich, K. W., Tierney, W. M., & Wolinsky, F. D. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(99)00071-2 · Cited by 862
Predicting Survival in Idiopathic Pulmonary Fibrosis
KING, T. E., TOOZE, J. A., SCHWARZ, M. I., BROWN, K. R., & CHERNIACK, R. M. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.7.2003140 · Cited by 853
Self-citationinternational consensus statement
Clements, R. V., & Simanowitz, A. (2000) · Cited by 852
Effect of encouragement on walking test performance.
Guyatt, G. H., Pugsley, S. O., Sullivan, M. J., Thompson, P. J., Berman, L., Jones, N. L., Fallen, E. L., & Taylor, D. W. (1984) · Thorax · doi:10.1136/thx.39.11.818 · Cited by 815
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
Collard, H. R., King, T. E., Bartelson, B. B., Vourlekis, J. S., Schwarz, M. I., & Brown, K. K. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200211-1311oc · Cited by 764
Self-citationCahalin, L. P., Mathier, M. A., Semigran, M. J., Dec, G. W., & DiSalvo, T. G. (1996) · Chest · doi:10.1378/chest.110.2.325 · Cited by 762
Guidelines for the six-minute walk test
Ats, S. (2002) · Medical Entomology and Zoology · Cited by 651
Fibrotic Idiopathic Interstitial Pneumonia: The Prognostic Value of Longitudinal Functional Trends
Latsi, P. I., du Bois, R. M., Nicholson, A. G., Colby, T. V., Bisirtzoglou, D., Nikolakopoulou, A., Veeraraghavan, S., Hansell, D. M., & Wells, A. U. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200210-1245oc · Cited by 583
Wyrwich, K. W., Nienaber, N. A., Tierney, W. M., & Wolinsky, F. D. (1999) · Medical Care · doi:10.1097/00005650-199905000-00006 · Cited by 569
Six minute walking test for assessing exercise capacity in chronic heart failure.
Lipkin, D. P., Scriven, A. J., Crake, T., & Poole-Wilson, P. A. (1986) · BMJ · doi:10.1136/bmj.292.6521.653 · Cited by 560
Prognostic Implications of Physiologic and Radiographic Changes in Idiopathic Interstitial Pneumonia
Flaherty, K. R., Mumford, J. A., Murray, S., Kazerooni, E. A., Gross, B. H., Colby, T. V., Travis, W. D., Flint, A., Toews, G. B., Lynch, J. P., et al. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200209-1112oc · Cited by 513
Validation of a New Dyspnea Measure
Eakin, E. G., Resnikoff, P. M., Prewitt, L. M., Ries, A. L., & Kaplan, R. M. (1998) · Chest · doi:10.1378/chest.113.3.619 · Cited by 422
Ries, A. L. (2005) · COPD: Journal of Chronic Obstructive Pulmonary Disease · doi:10.1081/copd-200050655 · Cited by 405
Six-Minute-Walk Distance Predicts Waiting List Survival in Idiopathic Pulmonary Fibrosis
Lederer, D. J., Arcasoy, S. M., Wilt, J. S., D'Ovidio, F., Sonett, J. R., & Kawut, S. M. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-520oc · Cited by 402
Yost, K. J., & Eton, D. T. (2005) · Evaluation & the Health Professions · doi:10.1177/0163278705275340 · Cited by 382
Interpretation of treatment changes in 6-minute walk distance in patients with COPD
Puhan, M. A., Mador, M. J., Held, U., Goldstein, R., Guyatt, G. H., & Schünemann, H. J. (2008) · European Respiratory Journal · doi:10.1183/09031936.00140507 · Cited by 373
Zappala, C. J., Latsi, P. I., Nicholson, A. G., Colby, T. V., Cramer, D., Renzoni, E. A., Hansell, D. M., du Bois, R. M., & Wells, A. U. (2010) · European Respiratory Journal · doi:10.1183/09031936.00155108 · Cited by 372
Assessment of Health-Related Quality of Life in Patients With Interstitial Lung Disease
Chang, J. A., Curtis, J. R., Patrick, D. L., & Raghu, G. (1999) · Chest · doi:10.1378/chest.116.5.1175 · Cited by 302
Six-Minute Walk, Maximal Exercise Tests: Reproducibility in Fibrotic Interstitial Pneumonia
Eaton, T., Young, P., Milne, D., & Wells, A. U. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200405-578oc · Cited by 274
Commentary—Goodbye M(C)ID! Hello MID, Where Do You Come From?
Schünemann, H. J., & Guyatt, G. H. (2005) · Health Services Research · doi:10.1111/j.1475-6773.2005.0k375.x · Cited by 247
Commentary--goodbye M(C)ID! Hello MID, where do you come from?
Schünemann, H. J., & Guyatt, G. H. (2005) · PubMed · doi:10.1111/j.1475-6773.2005.00374.x · Cited by 210
Six-Minute Walk Test and Health Status Assessment in Sarcoidosis
Baughman, R. P., Sparkman, B. K., & Lower, E. E. (2007) · Chest · doi:10.1378/chest.06-2822 · Cited by 203
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Hallstrand, T. S., Boitano, L. J., Johnson, W. C., Spada, C. A., Hayes, J. G., & Raghu, G. (2005) · European Respiratory Journal · doi:10.1183/09031936.04.00137203 · Cited by 188
The distance-saturation product predicts mortality in idiopathic pulmonary fibrosis
Lettieri, C. J., Nathan, S. D., Browning, R. F., Barnett, S. D., Ahmad, S., & Shorr, A. F. (2006) · Respiratory Medicine · doi:10.1016/j.rmed.2006.02.004 · Cited by 184
Determination of the clinical importance of study results: A review
Man-Son-Hing, M., Laupacis, A., O’Rourke, K., Molnar, F. J., Mahon, J., Chan, K. B. Y., & Wells, G. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.11111.x · Cited by 180
Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis
Caminati, A., Bianchi, A., Cassandro, R., Mirenda, M. R., & Harari, S. A. (2008) · Respiratory Medicine · doi:10.1016/j.rmed.2008.07.022 · Cited by 171
Reanalysis of the 12-Minute Walk in Patients With Chronic Obstructive Pulmonary Disease
Bernstein, M. L., Despars, J. A., Singh, N. P., Avalos, K., Stansbury, D. W., & Light, R. W. (1994) · Chest · doi:10.1378/chest.105.1.163 · Cited by 164
Swigris, J. J., Wamboldt, F. S., Behr, J., du Bois, R. M., King, T. E., Raghu, G., & Brown, K. K. (2009) · Thorax · doi:10.1136/thx.2009.113498 · Cited by 164
Self-citationSmall changes in six-minute walk distance are important in diffuse parenchymal lung disease
Holland, A. E., Hill, C. J., Conron, M., Munro, P. E., & McDonald, C. F. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.04.024 · Cited by 144
Chetta, A. A., Aiello, M., Foresi, A., Marangio, E., D’Ippolito, R., Castagnaro, A., & Olivieri, D. (2001) · PubMed · Cited by 77
Gomberg‐Maitland, M., Huo, D., Benza, R. L., McLaughlin, V. V., Tapson, V. F., & Barst, R. J. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2007.04.013 · Cited by 45
Nichol, M. B., & Epstein, J. (2008) · Quality of Life Research · doi:10.1007/s11136-008-9369-7 · Cited by 16
du Bois, R. M., Albera, C., Costabel, U., Bradford, W. Z., Kartashov, A. I., Noble, P. W., Szwarcberg, J., Thomeer, M., Valeyre, D., Weycker, D. A., et al. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm-conference.2010.181.1_meetingabstracts.a1103 · Cited by 8
Self-citation
Cited by
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Self-citationPirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
Noble, P. W., Albera, C., Bradford, W. Z., Costabel, U., Glassberg, M. K., Kardatzke, D., King, T. E., Lancaster, L., Sahn, S. A., Szwarcberg, J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60405-4 · Cited by 2,154
Self-citationWeill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329
“27 Prognostic factors in IPF have been reviewed in detail more recently, 26 and consistent clinical predictors of worse survival include older age, dyspnea, low or declining pulmonary function, 28 – 30 pulmonary hypertension, concomitant emphysema, extensive radiographic involvement, low exercise…”
Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis
Richeldi, L., Costabel, U., Selman, M., Kim, D. S., Hansell, D. M., Nicholson, A. G., Brown, K. K., Flaherty, K. R., Noble, P. W., Raghu, G., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103690 · Cited by 1,157
Self-citationSarcopenia with limited mobility: an international consensus
Morley, J. E., Abbatecola, A. M., Argiles, J. M., Baracos, V., Bauer, J., Bhasin, S., Cederholm, T., Stewart Coats, A. J., Cummings, S. R., Evans, W. J., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.04.014 · Cited by 1,125
Metadata
- Authors
- Bois, R. M. D., Weycker, D., Albera, C., Bradford, W. Z., Costabel, U., Kartashov, A., Lancaster, L., Noble, P. W., Sahn, S. A., Szwarcberg, J., Thomeer, M., Valeyre, D., & King, T. E.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-05-01
- Volume
- 183
- Issue
- 9
- Pages
- 1231-1237
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- OpenAlex
- W2100554882
- Cited by
- 465
- References
- 41
- FWCI
- 20.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.